Genmab A/S (GMAB) Commences New Arbitration Under License Agreement With Janssen

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/11/2026


Go back to Genmab A/S (GMAB) Commences New Arbitration Under License Agreement With Janssen

Genmab Commences New Arbitration Under License Agreement With Janssen

June 9, 2022 5:17 PM UTC

Company Announcement

COPENHAGEN, Denmark; June 9, 2022 Genmab A/S (Nasdaq: GMAB) announced today that it has commenced a new arbitration under its license agreement with Janssen Biotech, Inc. (Janssen) for daratumumab.

... More